Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillation.
Pan YQ, Jin LS, Qian S, Jiang T, Wang ZN, Chen YL, Qiu YX, Wu YH, Fu JY, Li L, Lin YN, Li YC.
Pan YQ, et al. Among authors: lin yn.
Front Pharmacol. 2024 Feb 22;15:1344828. doi: 10.3389/fphar.2024.1344828. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38455964
Free PMC article.